We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 84 results
  1. High prevalence of CD44 and its ligand low molecular weight hyaluronan in plasma of HNSCC patients: clinical significance

    Background

    This study aims to evaluate the role of cancer stem cell marker, CD44, and its ligand HA as potential molecular biomarker for early...

    Rituparna Roy, Nilanjana Chatterjee, ... Sankhadeep Dutta in Molecular Biology Reports
    Article 22 January 2024
  2. CD44: Does CD44v6 Adversely Impact the Prognosis of Cancer Patients?

    Colorectal cancer (CRC) is the third leading cause of cancer-related death in the USA. This high level of CRC death is primarily due to...
    Shibnath Ghatak, Vincent C. Hascall, ... Suniti Misra in Hyaluronan
    Chapter 2023
  3. Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells

    Background

    Expression of CD44 receptor is associated with the onset of several tumors. The intracellular domain of CD44 (CD44-ICD) has been implicated...

    Linda T. Senbanjo, Hanan AlJohani, ... Meenakshi A. Chellaiah in Cell Communication and Signaling
    Article Open access 22 July 2019
  4. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram

    Background

    The current successful clinical use of agents promoting robust anti-tumor immunity in cancer patients warrants noting that radiation...

    Ting Sun, Wei Yang, ... **nhui Wang in Cell Communication and Signaling
    Article Open access 05 March 2020
  5. Loss of Epidermal Homeostasis Underlies the Development of Squamous Cell Carcinoma

    Squamous cell carcinoma (SCC) is one of the most common skin cancers. To develop targeted therapies for SCC, a comprehensive understanding of the...

    Alok Jaiswal, Raghvendra Singh in Stem Cell Reviews and Reports
    Article 15 December 2022
  6. The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells

    N-terminal HSP90 inhibitors in development have had issues arising from heat shock response (HSR) induction and off-target effects. We sought to...

    Soeun Park, Yoon-Jae Kim, ... Jae Hong Seo in Cell Death Discovery
    Article Open access 13 November 2021
  7. CD44a functions as a regulator of p53 signaling, apoptosis and autophagy in the antibacterial immune response

    The cell adhesion molecule CD44 has been implicated in diverse biological functions including the pathological responses to infections and...

    Lu Cao, Hong Fang, ... Ming **an Chang in Communications Biology
    Article Open access 30 August 2022
  8. Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma

    Background

    Mesenchymal stromal cells (MSCs) tropism for tumours allows their use as carriers of antitumoural factors and in vitro transcribed mRNA...

    María José Cantero, Barbara Bueloni, ... Mariana G. García in Stem Cell Research & Therapy
    Article Open access 11 July 2024
  9. Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loop

    Enhancement of Wnt signaling is fundamental for stem cell function during intestinal regeneration. Molecular modules control Wnt activity by...

    Romina J. Walter, Steffen J. Sonnentag, ... Véronique Orian-Rousseau in Cell Death & Disease
    Article Open access 21 February 2022
  10. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL

    NOTCH1 alterations have been associated with chronic lymphocytic leukemia (CLL), but the molecular mechanisms underlying NOTCH1 activation in CLL...

    Filomena De Falco, Chiara Rompietti, ... Emanuela Rosati in Cell Death & Disease
    Article Open access 01 September 2022
  11. Cancer treatment therapies: traditional to modern approaches to combat cancers

    As far as health issues are concerned, cancer causes one out of every six deaths around the globe. As potent therapeutics are still awaited for the...

    Rasanpreet Kaur, Alok Bhardwaj, Saurabh Gupta in Molecular Biology Reports
    Article 12 October 2023
  12. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance

    Iron-dependent lipid peroxidation causes ferroptosis, a form of regulated cell death. Crucial steps in the formation of ferroptosis include the...

    Yuqing Ren, **angrong Mao, ... Guojun Zhang in Cellular and Molecular Life Sciences
    Article Open access 19 August 2023
  13. Nanozyme-Based Enhanced Cancer Immunotherapy

    Catalytic nanoparticles with natural enzyme-mimicking properties, known as nanozymes, have emerged as excellent candidate materials for cancer...

    Ngoc Man Phan, Thanh Loc Nguyen, Jaeyun Kim in Tissue Engineering and Regenerative Medicine
    Article 31 January 2022
  14. Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity

    Cancer immunotherapy has transformed traditional treatments, with immune checkpoint blockade being particularly prominent. However, immunotherapy has...

    Senbo Liu, Wenkang Wang, ... Zhenqiang Sun in Cell Death & Disease
    Article Open access 13 October 2023
  15. Necroptosis stimulates interferon-mediated protective anti-tumor immunity

    Necroptosis is an inflammatory form of cell suicide that critically depends on the kinase activity of Receptor Interacting Protein Kinase 3 (RIPK3)....

    A. Justin Rucker, Christa S. Park, ... Francis Ka-Ming Chan in Cell Death & Disease
    Article Open access 10 June 2024
  16. An oncolytic virus–T cell chimera for cancer immunotherapy

    The efficacy of oncolytic adenoviruses (OAs) for cancer therapy has been limited by insufficient delivery to tumors after systemic injection and the...

    Yuxuan Chen, **aohong Chen, ... Yuan ** in Nature Biotechnology
    Article 09 February 2024
  17. Cuproptosis in cancer: biological implications and therapeutic opportunities

    Cuproptosis, a newly identified copper (Cu)-dependent form of cell death, stands out due to its distinct mechanism that sets it apart from other...

    Li** Li, Houfeng Zhou, Chenliang Zhang in Cellular & Molecular Biology Letters
    Article Open access 25 June 2024
  18. CD74 is a functional MIF receptor on activated CD4+ T cells

    Next to its classical role in MHC II-mediated antigen presentation, CD74 was identified as a high-affinity receptor for macrophage migration...

    Lin Zhang, Iris Woltering, ... Adrian Hoffmann in Cellular and Molecular Life Sciences
    Article Open access 11 July 2024
  19. Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade

    Reversing the highly immunosuppressive tumor microenvironment (TME) is essential to achieve long-term efficacy with cancer immunotherapy. Despite the...

    Yang Liu, **g Cai, ... Jiankai Liang in Cell Death & Disease
    Article Open access 12 December 2020
  20. TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer

    ATP and its receptor P2RX7 exert a pivotal effect on antitumor immunity during chemotherapy-induced immunogenic cell death (ICD). Here, we...

    Kevin Chih-Yang Huang, Shu-Fen Chiang, ... K. S. Clifford Chao in Cell Death & Disease
    Article Open access 09 January 2024
Did you find what you were looking for? Share feedback.